Back
Essilorluxottica Vs. NovoCure Industry Stock Comparison
Buy
61
ESLOY
Essilorluxottica
Last Price:
119.78
Seasonality Move:
2.26%
Buy
82
NVCR
NovoCure
Last Price:
30.52
Seasonality Move:
2.04%
Buy
61
Essilorluxottica (ESLOY)
is a Buy
Is Essilorluxottica a Buy, Sell or Hold?
- The current Essilorluxottica [ESLOY] share price is $119.78. The Score for ESLOY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- ESLOY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
82
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ESLOY Stock Price Chart
What is Essilorluxottica's stock price today?
-
The Essilorluxottica share price today is $119.78
The current trend is moderately bearish and ESLOY is experiencing slight buying pressure.
NVCR Stock Price Chart
ESLOY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 46.67 | Sell |
| Chaikin Money Flow: | 14666 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (118.74 - 122.96) | Sell |
| Bollinger Bands (100): | (112.27 - 120.79) | Buy |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.24 | Buy |
| Relative Strength Index (14 RSI): | 84.56 | Buy |
| Chaikin Money Flow: | -690353 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.69 - 22.01) | Buy |
| Bollinger Bands (100): | (15.44 - 20.28) | Buy |
ESLOY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.52 | Sell |
| 20-day SMA: | 121.67 | Sell |
| 50-day SMA: | 118.95 | Buy |
| 200-day SMA: | 113.33 | Buy |
| 8-day EMA: | 121.25 | Sell |
| 20-day EMA: | 121.01 | Sell |
| 50-day EMA: | 119.36 | Buy |
| 200-day EMA: | 112.73 | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.45 | Buy |
| 20-day SMA: | 18.85 | Buy |
| 50-day SMA: | 17.12 | Buy |
| 200-day SMA: | 17.34 | Buy |
| 8-day EMA: | 23.1 | Buy |
| 20-day EMA: | 19.92 | Buy |
| 50-day EMA: | 18.23 | Buy |
| 200-day EMA: | 19.07 | Buy |
Essilorluxottica Earnings Growth & ESLOY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.
Essilorluxottica Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||